AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 1 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $551,781 | +302.8% | 53,571 | -4.8% | 0.02% | +250.0% |
| Q2 2022 | $137,000 | -35.7% | 56,300 | +80.4% | 0.01% | -33.3% |
| Q1 2022 | $213,000 | +56.6% | 31,200 | +85.7% | 0.01% | 0.0% |
| Q4 2021 | $136,000 | +47.8% | 16,803 | +22.5% | 0.01% | 0.0% |
| Q2 2021 | $92,000 | +16.5% | 13,712 | +16.7% | 0.01% | -30.8% |
| Q4 2020 | $79,000 | +46.3% | 11,754 | +9.9% | 0.01% | +18.2% |
| Q3 2020 | $54,000 | – | 10,691 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
| COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
| Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
| GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
| Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
| RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
| Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
| HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |